\
&
Contact us
\
&
Contact us
Published on | 4 years ago
ProgrammesThe European Commission has published further information on the ongoing call to establish an initial network of European Digital Innovation Hubs.
Based on questions received during two webinars on 18 November and on 14 December 2021 the Commission has published an updated version of its FAQ document (version 7 January 2022).
In addition, the Commission has published the recording and presentations held during a meeting with Member States representations on 11 January 2022 on co-funding and national strategy issues.
The presentation held during an earlier meeting (15/11/2021) on co-funding mechanisms is also available online.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
